A change in Y chromosome number is one of the many cytogenetic abnormalitie
s reported in human prostate tumors. However, reports in the literature hav
e varied regarding the frequency of Y loss or gain and the significance of
Y aneusomy viith respect to the biology of the disease. We have conducted a
n analysis of the Y chromosome in malignant and benign hyperplastic human p
rostate epithelium in order to determine whether regional Y loss occurs in
prostate cancer. To accomplish this we performed dual-color fluorescence in
situ hybridization (FISH) on serial sections of paraffin-embedded prostate
tumor tissues using either a Yp (SRY), Ycen (alpha-satellite) or Yq (satel
lite 3) probe, and an Xcen (alpha-satellite) probe that served as a control
for hybridization and nuclear truncation. The results of our FISH analysis
demonstrated loss of Yp in the malignant epithelium of 14/40 (35%) prostat
e tumor sections examined. We also found loss of Yq in 4/40 (10%) of the sa
mples, with one of these exhibiting accompanying Yp loss. The remaining sam
ples, 23/40 (58%), retained both Yp and Yq markers, with no evidence of eit
her Ycen loss or Y gain in any of the tumor samples examined; In addition,
Y loss was detected in the benign hyperplastic regions in nearly one-half o
f the tissue sections that exhibited Y loss in the malignant epithelium. Th
ese results demonstrate that regional chromosome Y loss occurs in prostate
cancer, that loss of Yp is the most frequent event, and suggest that this l
oss may in some cases be a precursor to prostate malignancy. (C) 2001 Elsev
ier Science Inc. All rights reserved.